Skip to content
Screener

Shares (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
Perrigo Company logo
Perrigo CompanyPRGO
139.6M+1.0%
HRO
HarrowHROW
37.4M-3.9%
Bausch Health Companies logo
Bausch Health CompaniesBHC
372.8M+0.9%
Cencora logo
CencoraCOR
193.9M-0.7%
Organon logo
OrganonOGN
262.9M+0.7%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.58B-30.3%
Enterprise value$4.55B-1.2%
P/E15×-2.4×
P/S2.3×-1.0×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands, except per share data)Three Months Ended June 30, 20262025
Diluted$0.61$0.95
Weighted average shares outstanding:
Basic47,46249,475
Diluted47,60449,833
Comprehensive income, net of tax:
Currency translation adjustments(1,310)5,404
Total other comprehensive (loss) income(1,310)5,404
Comprehensive income$27,867$52,870

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's shares (diluted)?
Prestige Consumer Healthcare (PBH) reported shares (diluted) of 47.6M in Q2 2026.
How has Prestige Consumer Healthcare's shares (diluted) changed year-over-year?
Prestige Consumer Healthcare's shares (diluted) decreased by 4.5% year-over-year, from 49.8M to 47.6M.
What is the long-term trend for Prestige Consumer Healthcare's shares (diluted)?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's shares (diluted) has grown at a -0.9% compound annual growth rate (CAGR), from 203.2M to 195.9M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Prestige Consumer Healthcare's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude